Cash flow generation is highly volatile due to working capital changes, as seen in the $2.3B drain in 2025Q1, and capital allocation has prioritized acquisitions with over $7.5B net deployed over the last ten quarters.
Cardinal Health, Inc. (CAH) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Dec'25 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 |
|---|
| Cash from Operations | 5.17B | 2.4B | 3.76B | 2.84B | 3.12B | 2.43B | 1.96B | 2.72B | 2.77B | 1.18B | 2.97B | 2.54B | 2.52B | 1.73B | 1.18B | 1.39B | 2.13B | 1.57B | 1.51B | 1.22B | 2.14B | 2.85B | 2.62B | 1.4B | 983.9M | 871.7M | 638.2M | 345.7M | 143.1M | 39.2M |
| Operating CF Margin % | 8.13% | 1.08% | 1.66% | 1.39% | 1.72% | 1.5% | 1.28% | 1.87% | 2.02% | 0.91% | 2.44% | 2.48% | 2.77% | 1.71% | 1.09% | 1.36% | 2.17% | 1.63% | 1.73% | 1.41% | 2.69% | 3.92% | 4.07% | 2.46% | 1.92% | 1.82% | 1.66% | 1.38% | 0.68% | 0.21% |
| Operating CF Growth % | 115.85% | -36.28% | 32.28% | -8.9% | 28.53% | 23.93% | -27.99% | -1.66% | 133.78% | -60.15% | 16.97% | 0.63% | 46.15% | 46.85% | -15.67% | -34.65% | 36.16% | 3.65% | 23.63% | -42.85% | -24.91% | 8.59% | 87.75% | 42.09% | 12.87% | 36.59% | 84.61% | 141.58% | 265.05% | -67.92% |
| Net Income | 1.71B | 1.57B | 853M | 331M | -933M | 612M | -3.69B | 1.36B | 259M | 1.29B | 1.43B | 1.21B | 1.16B | 335M | 1.07B | 966M | 587M | 758.2M | 847.2M | 1.93B | 1B | 1.05B | 1.52B | 1.38B | 1.14B | 857.4M | 717.8M | 481M | 448.5M | 334.8M |
| Depreciation & Amortization | 956M | 790M | 710M | 692M | 723M | 783M | 913M | 1B | 1.03B | 717M | 641M | 451M | 459M | 397M | 325M | 313.3M | 254.4M | 399.4M | 381.3M | 322.1M | 392.7M | 409.7M | 299.2M | 265.8M | 243.5M | 280.6M | 245.9M | 233.5M | 64.3M | 51.3M |
| Stock-Based Compensation | 367M | 244M | 121M | 96M | 0 | 89M | 90M | 82M | 85M | 96M | 111M | 110M | 96M | 93M | 85M | 79.5M | 99.5M | 122.8M | 122.3M | 138.1M | 237.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 91M | 243M | -104M | -40M | 7M | 496M | -961M | -83M | -1.01B | 291M | 87M | 219M | 26M | 21M | 158M | 128M | 120M | 69.5M | 26.9M | 11.7M | -5.7M | 54.7M | 102.8M | 215.2M | 239.7M | 149.1M | 128.5M | 132.4M | 90.1M | 32.9M |
| Other Non-Cash Items | -31M | 74M | 672M | 1.31B | 2.2B | 160M | -450M | -397M | 1.5B | 53M | 78M | 96M | 25M | 890M | -28M | -46M | 198M | 617.9M | 461.2M | -605.5M | 671.8M | 455.6M | -19M | 22.2M | 42.6M | 41.4M | 37.5M | 29.7M | 23.4M | 8.6M |
| Working Capital Changes | 2.09B | -523M | 1.51B | 457M | 1.12B | 289M | 6.06B | 755M | 907M | -1.27B | 623M | 452M | 755M | -9M | -434M | -46M | 875M | -357.4M | -121.5M | -436.3M | 157M | 999.1M | 733.2M | -486.4M | -682.7M | -456.8M | -636.8M | -503.7M | -208.4M | -96.4M |
| Change in Receivables | -408M | -833M | -996M | -950M | -1.53B | -904M | 82M | -751M | -871M | -665M | -866M | -870M | 925M | 216M | -129M | -457M | 21M | -713.6M | -296.1M | -783.1M | -895.3M | -15.9M | -411.7M | -413.7M | 142.7M | -31.4M | -377.3M | -214.5M | -211.7M | -15.3M |
| Change in Inventory | -488M | -1.82B | 1.11B | -412M | -1.07B | -1.58B | -409M | -551M | -1.21B | -673M | -1.18B | -779M | 142M | -370M | -495M | -665M | 477M | -431.2M | 634.3M | 217.4M | -356.1M | 71.6M | 237.5M | -217.9M | -1.07B | -1.52B | -1.07B | -317.9M | -474.3M | -106.6M |
| Change in Payables | 3.46B | 2.73B | 1.82B | 2.82B | 3.43B | 2.33B | -162M | 1.86B | 2.57B | 564M | 2.81B | 1.95B | -196M | 426M | 319M | 1.36B | 451M | 768.1M | -848.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -2.58B | -5.61B | -1.85B | -454M | 567M | -378M | 493M | 338M | -5.61B | -405M | -4.08B | -849M | -850M | -2.38B | -377M | -2.03B | 127.1M | -542.9M | -726.4M | 1.54B | -1.19B | -877.4M | -2.44B | -343.7M | -650.9M | -633.4M | -287.3M | -409.6M | -112.2M | -17.9M |
| Capital Expenditures | -649M | -547M | -511M | -481M | -387M | -400M | -375M | -328M | -384M | -387M | -465M | -300M | -249M | -195M | -263M | -291.3M | -255.8M | -533.4M | -376.1M | -357.4M | -443.2M | -571.7M | -410.2M | -423.2M | -285.4M | -341.2M | -307.8M | -467.4M | -114.7M | -75.2M |
| CapEx % of Revenue | 1.02% | 0.25% | 0.23% | 0.23% | 0.21% | 0.25% | 0.25% | 0.23% | 0.28% | 0.3% | 0.38% | 0.29% | 0.27% | 0.19% | 0.24% | 0.28% | 0.26% | 0.56% | 0.43% | 0.41% | 0.56% | 0.79% | 0.64% | 0.75% | 0.56% | 0.71% | 0.8% | 1.86% | 0.54% | 0.41% |
| Acquisitions | -1.99B | -5.25B | -1.19B | -10M | 901M | -3M | 0 | -82M | -6.14B | -132M | -3.61B | -503M | -519M | -2.24B | -174M | -2.3B | -32M | -128.6M | -4.7M | -1.63B | -362.2M | -273.2M | -2.09B | -26.8M | -383.8M | -364.3M | -69.6M | -147.5M | -45.8M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 15M | -10M | 18M | 8M | 31M | 0 | 2M | 763M | 862M | 3M | 13M | 53M | 0 | 0 | 0 | 3M | 148M | -6M | -697.9M | 3.16B | -86.6M | -163.2M | 48.7M | 106.3M | 18.3M | 72.1M | 60.2M | 57.9M | 6.1M | 23.5M |
| Cash from Financing | -1.6B | 1.95B | -847M | -3.05B | -2.46B | -1.32B | -2.2B | -2.29B | -2.28B | 3.75B | -1.14B | 60M | -710M | 275M | -454M | -192.6M | -727.5M | -468.2M | -803.2M | -2.64B | -1.03B | -1.66B | -815.7M | -712.3M | 114.9M | 108.7M | -31.7M | -141.8M | 31M | -82.5M |
| Debt Issued (Net) | 337M | 3.22B | 356M | -579M | -885M | -570M | -1.4B | -1.1B | -1B | 4.86B | 20M | 1.44B | 112M | 980M | 258M | 312M | -1.49B | -304.2M | 296.4M | 630.5M | 299.8M | -1.21B | 512.8M | 326.9M | 333M | 32.6M | 372.7M | -102.2M | -26.9M | -368.5M |
| Equity Issued (Net) | -1.36B | -765M | -750M | -2B | -1B | -200M | -350M | -600M | -550M | -600M | -651M | -1.04B | -673M | -329M | -408M | -207M | -190M | 39.2M | -953.7M | -3.11B | -1.26B | -389.8M | -1.28B | -994.4M | -168.3M | 112.7M | -243.9M | 14.3M | -95.8M | 70.5M |
| Dividends Paid | -491M | -494M | -499M | -525M | -559M | -573M | -569M | -577M | -581M | -577M | -512M | -460M | -415M | -353M | -300M | -274.2M | -253.1M | -200.4M | -173.1M | -144.4M | -101.8M | -51.7M | -52.3M | -44.8M | -45M | -36.6M | -28M | -56.7M | -11.5M | -9.1M |
| Share Repurchases | -1.36B | -765M | -750M | -2B | -1B | -200M | -350M | -600M | -550M | -600M | -651M | -1.04B | -673M | -450M | -450M | -270M | -230M | 0 | -1.18B | -3.66B | -1.5B | -500.3M | -1.5B | -1.19B | -308.3M | -139.4M | -341.4M | -47.8M | -155M | -37.7M |
| Other Financing | -90M | -13M | 46M | 53M | -19M | 26M | 120M | -14M | -144M | 59M | 4M | 117M | 266M | -23M | -4M | -23.4M | 1.2B | -2.8M | 27.2M | -15.5M | 28.9M | -6.9M | 7.1M | 0 | -4.8M | 0 | -130.5M | -19M | -40.8M | -41.7M |
| Net Change in Cash | 982M | -1.26B | 1.06B | -669M | 1.31B | 636M | 240M | 768M | -5.12B | 4.52B | -2.26B | 1.75B | 964M | -373M | 345M | -826M | 1.53B | 556.2M | -17.5M | 121.5M | -79.1M | 315.7M | -628M | 342M | 447.9M | 347M | 319.2M | -208.1M | 61.9M | -61.2M |
| Free Cash Flow | 4.53B | 1.85B | 3.25B | 2.36B | 2.73B | 2.03B | 1.58B | 2.39B | 2.38B | 797M | 2.51B | 2.24B | 2.27B | 1.53B | 913M | 1.1B | 1.88B | 1.03B | 1.14B | 865.7M | 1.7B | 2.28B | 2.21B | 974.8M | 698.5M | 530.5M | 330.4M | -121.7M | 28.4M | -36M |
| FCF Margin % | 7.11% | 0.83% | 1.43% | 1.15% | 1.51% | 1.25% | 1.04% | 1.65% | 1.74% | 0.61% | 2.06% | 2.18% | 2.5% | 1.52% | 0.85% | 1.07% | 1.91% | 1.08% | 1.3% | 1% | 2.13% | 3.14% | 3.43% | 1.72% | 1.37% | 1.11% | 0.86% | -0.48% | 0.13% | -0.2% |
| FCF Growth % | 144.59% | -43.09% | 37.58% | -13.6% | 34.8% | 28.01% | -33.79% | 0.42% | 199.12% | -68.2% | 11.88% | -1.54% | 48.5% | 67.8% | -17.25% | -41.26% | 81.67% | -8.99% | 31.22% | -48.99% | -25.52% | 2.89% | 127.17% | 39.56% | 31.67% | 60.56% | 371.49% | -528.52% | 178.89% | -173.32% |
| FCF per Share | 19.26 | 7.64 | 13.16 | 9.02 | 9.80 | 6.90 | 5.41 | 7.95 | 7.57 | 2.49 | 7.59 | 6.69 | 6.59 | 4.45 | 2.62 | 3.13 | 5.20 | 2.86 | 3.12 | 2.14 | 3.96 | 5.23 | 5.15 | 2.15 | 1.54 | 1.14 | 0.73 | -0.28 | 0.07 | -0.15 |
| FCF Conversion (FCF/Net Income) | 13.00x | 1.54x | 4.42x | 8.62x | -3.33x | 3.98x | -0.53x | 2.00x | 10.81x | 0.92x | 2.08x | 2.09x | 2.16x | 5.17x | 1.10x | 1.45x | 3.32x | 1.36x | 1.16x | 0.63x | 2.14x | 2.71x | 1.78x | 0.99x | 0.93x | 1.02x | 0.94x | 0.76x | 0.58x | 0.22x |
| Interest Paid | 406M | 315M | 214M | 203M | 0 | 182M | 226M | 285M | 320M | 200M | 174M | 150M | 152M | 128M | 118M | 116M | 158M | 201.8M | 239.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 338M | 444M | 191M | 156M | 0 | 273M | 368M | 311M | 425M | 686M | 635M | 529M | 632M | 899M | 513M | 588M | 514M | 429.3M | 116M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CAH stock.
Cardinal Health, Inc. (CAH) generated $5.17B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.
Cardinal Health, Inc. (CAH) generated $4.53B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Cardinal Health, Inc. (CAH) spent $649.0M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2026, Cardinal Health, Inc. (CAH) returned $491.0M to shareholders via cash dividends and spent $1.36B on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Working capital volatility
Metrics are mathematically derived from official filings.
Earnings Quality Eroded by Working Capital Swings
Operating cash flow frequently diverges from net income, exemplified by a negative $1.6B OCF in 2025Q1 despite $416M net income, as reported in cash flow statements, highlighting severe distortions from inventory and receivables timing.
The OCF/NI ratio has been wildly inconsistent, ranging from -3.96 to 8.80 over ten quarters, indicating that reported earnings are an unreliable proxy for cash generation. This volatility is primarily driven by massive, unpredictable working capital swings, which suggest the business model creates inherent cash flow instability that obscures underlying operational performance.
FCF Swings Undermine Capital Return Capacity
Free cash flow has been erratic, plunging to -$1.7B in 2025Q1 before surging to $2.8B in 2025Q3, per the provided data, reflecting how working capital and acquisition timing overwhelm core operational cash generation.
Despite recent strong quarters, the historical pattern of negative FCF quarters implies that the company's ability to consistently fund dividends and buybacks may be constrained during periods of working capital expansion. The volatile trajectory complicates long-term financial planning and suggests that reported net income is not translating into predictable, sustainable free cash flow.
Extreme WC Swings Dominate Cash Profile
Working capital changes have swung from a $2.3B cash drain in 2025Q1 to a $1.2B source in 2026Q4, as shown in the financial data, demonstrating that inventory and receivables management are the primary drivers of quarterly cash flow volatility.
These massive fluctuations, often exceeding net income by several times, indicate a structural vulnerability in the high-volume distribution model where short-term cash positioning is dictated by payment cycles with suppliers and customers. The lack of stability in this metric suggests investors should focus on multi-year cash flow trends rather than quarterly figures, as single-period results are heavily distorted.
Acquisition-Focused Allocation Amidst Cash Uncertainty
Over the last ten quarters, Cardinal Health deployed over $7.5B net for acquisitions and over $2.8B for share repurchases, based on cash flow data, while maintaining a steady quarterly dividend near $120M.
The significant acquisition outflows, particularly the $2.8B in 2025Q3, indicate a continued reliance on M&A for growth, which is a capital-intensive strategy that exacerbates cash flow volatility. The commitment to dividends and buybacks despite erratic free cash flow implies management is willing to utilize balance sheet capacity to return capital, a practice that warrants monitoring for sustainability if core cash generation does not stabilize.
Non-Cash Items and Litigation Cloud True Cash Generation
Stock-based compensation totaled $751M over the past ten quarters, and opioid-related litigation charges are excluded from operating cash flow, as noted in SEC filings, which may overstate the recurring cash-generating power of the core business.
While SBC is a non-cash charge, its substantial and growing total represents real economic dilution to shareholders that is not captured in standard free cash flow metrics. Furthermore, the exclusion of large, episodic litigation settlement payments from operating cash flow creates a cleaner but potentially misleading picture of normalized cash generation, requiring careful adjustment to assess the true underlying cash flow of the distribution operations.